Bupropion Hydrochloride
NDC 50436-1580
Product Information
Bupropion Hydrochloride is a ANDA-approved product labeled by Unit Dose Services. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a purple product. This product entry covers the primary NDC 50436-1580 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
ORANGE (C48331)
8 MM
APO;BUP;100
APO;BU;75
Code Structure Chart
Product Details
What is NDC 50436-1580?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BUPROPION HYDROCHLORIDE (UNII: ZG7E5POY8O)
- BUPROPION (UNII: 01ZG3TPX31) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- CROSPOVIDONE (15 MPA.S AT 5%) (UNII: 68401960MK)
- D&C RED NO. 7 (UNII: ECW0LZ41X8)
- FUMARIC ACID (UNII: 88XHZ13131)
- HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- METHYLCELLULOSE (100 MPA.S) (UNII: 4GFU244C4J)
- POLYETHYLENE GLYCOL 8000 (UNII: Q662QK8M3B)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 993687 - buPROPion HCl 100 MG Oral Tablet
- RxCUI: 993687 - bupropion hydrochloride 100 MG Oral Tablet
- RxCUI: 993691 - buPROPion HCl 75 MG Oral Tablet
- RxCUI: 993691 - bupropion hydrochloride 75 MG Oral Tablet
- RxCUI: 993691 - bupropion HCl 75 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.